NCT03510676View on ClinicalTrials.gov

The ILLUMINA Study. (ILLUMINA)

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 26, 2016

Primary Completion Date

March 7, 2018

Study Completion Date

March 7, 2019

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

NiTiDES

Trial Locations (10)

10713

St. Gertrauden Krankenhaus GmbH, Berlin

20132

San Raffaele Hospital, Milan

27100

IRCCS Policlinico San Matteo, Pavia

31076

Clinique Pasteur, Toulouse

48033

Maria Cecilia Hospital, Cotignola

79189

Universitäts-Herzzentrum Freiburg, Bad Krozingen

83190

Polyclinique Les Fleurs, Ollioules

91480

Centre Privé Claude Galien, Quincy-sous-Sénart

96515

Regiomed GefäBzentrum Sonneberg, Sonneberg

04103

Universitätsklinikum Leipzig, Leipzig

All Listed Sponsors
lead

CID - Carbostent & Implantable Devices

INDUSTRY

NCT03510676 - The ILLUMINA Study. (ILLUMINA) | Biotech Hunter | Biotech Hunter